Conference LibraryGated
Cancers 2025 · Review: CAR therapies ex vivo and in vivo · biomimetic nanoparticles
"Chimeric antigen receptor (CAR) therapy represents a promising modality for treating cancer and autoimmune diseases, employing genetically engineered immune cells. Despite remarkable clinical outcomes, its broad implementation is constrained by significant challenges, including…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_intel_seed_2026-05-16
- evidence_grade
- A
- category
- in_vivo_car_t_review
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "review article · industry framing · NOT primary clinical data"
- journal
- Cancers (Basel)
- year
- 2025
- authors
- Ekaterina Tkachenko,Peter Timashev
- abstract_snippet
- "Chimeric antigen receptor (CAR) therapy represents a promising modality for treating cancer and autoimmune diseases, employing genetically engineered immune cells. Despite remarkable clinical outcomes, its broad implementation is constrained by significant challenges, includ
- pmid
- 41374968
- doi
- 10.3390/cancers17233766
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.